Announcements Trials
Browse Landscape

Phase

Phase NA 14Phase 1 11Phase 2 9Phase 1/2 4Phase 3 1

Status

Completed 147Recruiting 48Unknown 46Terminated 25Active not recruiting 24Not yet recruiting 12Withdrawn 8Suspended 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 7Gastrointestinal 4Thoracic 3Other hematologic neoplasm 3Gynecologic 3Lymphoid 2Genitourinary 2Classical hematology 2Tumor-Agnostic 1Sarcoma 1Plasma cell 1Other 1Myeloid 1Head & Neck 1Dermatologic 1CNS 1

Conditions

Glioblastoma 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Suspended × CNS × Clear all
NCT02546102 2024-04-03

Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma

Precision Life Sciences Group

Phase 3 Suspended
234 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡